Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study

Chih Hung Hsu, Yoon Koo Kang, Tsai Shen Yang, Chia Tung Shun, Yu Yun Shao, Wu Chou Su, Jennifer Sandoval-Tan, Tzeon Jye Chiou, Kate Jin, Chiun Hsu, Ann Lii Cheng

研究成果: 雜誌貢獻文章同行評審

39 引文 斯高帕斯(Scopus)

指紋

深入研究「Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study」主題。共同形成了獨特的指紋。

Medicine & Life Sciences